Please turn JavaScript on
Drug Development and Delivery icon

Drug Development and Delivery

Want to stay in touch with the latest updates from Drug Development and Delivery? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Drug Development & Delivery - The Latest Methods in Drug Development

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.84 / day

Message History

By: Cindy H. Dubin, Managing Editor

Markus Burkert, Product Manager Cartridge & Sustainability, Syntegon

In June, the World Health Organization (WHO) published a draft guidance to assist regulators and pharma companies in integrating environmental sustainability strategies and metrics into drug manufacturing. The guide...


Read full story
Baar – SGS, the world’s leading testing, inspection and certification company, has expanded its Saint-Benoît laboratory, a strategic site dedicated to pharmaceutical bioanalysis and drug development for the pharmaceutical and biotechnology industries. Located near Poitiers, France, the laboratory has been recognized as a key player for more than 35 years, supporting clients ...

Read full story

Barcelona, Spain, – Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced the completion of the clinical portion of SPARTA (Study of ProlAstin-C Randomized Therapy with Alpha-1 augmentation; NCT01983241


Read full story

PRINCETON, N.J.- Bristol Myers Squibb today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion investment designed to accelerate the delivery of next-generation medicines to patients. The campus, at Generation Park in Houston, will create nearly 500 skilled jobs and is...


Read full story

SCHÖNEFELD, Germany, — Kupando, a pioneering biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity and induces trained immunity for use in oncology and infectious diseases, today announced that the first patient has been successfully dosed in its...


Read full story